Bates wins more Pfizer work

Published on .

Pfizer, New York, assigned its estimated $20 million Visine account to Bates USA without a review. The brand had been with Bates for 27 years until 1992, when what is now the Wolf Group picked it up. Two weeks ago, Pfizer shifted to Bates its Rolaids and Zantac accounts, from J. Walter Thompson USA, and the Bonine and Desatin accounts, from Bozell.

Copyright November 2000, Crain Communications Inc.

In this article:
Most Popular